PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

Medicare GLP-1 Bridge Has a BIG Catch: Who Gets Left Behind?

13:24Sep 2026

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The creator explains a catch in the Medicare GLP-1 Bridge Program, which she says launched in July 2026 as a temporary demonstration. According to the video, it covers Wegovy, the QuickPen from Zepbound, and Foundayo for eligible beneficiaries at a $50 monthly copay, for weight management. Eligibility depends on BMI and health condition requirements, not weight alone.

Published by Beyond the Scale: My GLP-1 Journey on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The central issue, she says, is that people with type 2 diabetes, moderate to severe obstructive sleep apnea, or non-cirrhotic MASH with moderate to advanced liver scarring are not eligible for Bridge. CMS wording she shows states this applies even if the person's Part D plan does not cover a GLP-1 for that condition. She describes an NPR story about 68-year-old Jeff LaMarca, who has a BMI of 42, is pre-diabetic, had quadruple bypass surgery and has severe sleep apnea. His Bridge application was denied, and his Zepbound prescription, priced at about $750 a month, remained unfilled. She adds that Part D may involve prior authorization, formulary limits or step therapy, and that physicians told NPR patients' shares can reach 200, 600 or more per month.

She also notes the program is helping many people, citing reports of about 100,000 Bridge prescriptions each at CVS and Walgreens in the first weeks. She says CMS rules bar people who received a GLP-1 through Part D in 2026 from Bridge in 2026. She closes with suggestions to ask your plan why you were denied, ask about appeals, and make sure your provider submits through the correct pathway.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:35 She says the Bridge Program launched in July 2026 as a temporary demonstration with a $50 monthly copay for eligible people.
  2. 1:49 She explains that people with type 2 diabetes, moderate to severe sleep apnea, or certain MASH are directed to Part D instead of Bridge.
  3. 3:12 She relays the NPR story of Jeff LaMarca, whose Bridge application was denied partly because of severe sleep apnea.
  4. 5:21 She says Part D coverage can still carry prior authorization, step therapy and monthly costs of hundreds of dollars.
  5. 7:55 She says CMS rules make people who got a GLP-1 through Part D in 2026 ineligible for Bridge in 2026.
  6. 11:03 She advises asking your plan why you were denied, asking about appeals, and confirming the prescription goes through the correct pathway.

Key moments

Tap one to play from there.

  1. 0:00 Intro and the Medicare Bridge catch that people may not be a
  2. 0:55 What is the Medicare Bridge program?
  3. 1:44 Here's where things get complicated
  4. 3:28 Meet Jeff La Marca
  5. 5:11 So what happens next?
  6. 8:14 Why did Medicare create this system in the first place?
  7. 9:43 Another question we need to ask
  8. 10:47 So where does that leave Medicare patients?

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound

Questions this video answers

Who is not eligible for the Medicare GLP-1 Bridge Program?

According to the video, CMS says people diagnosed with type 2 diabetes, moderate to severe obstructive sleep apnea, or non-cirrhotic MASH with moderate to advanced liver scarring are not eligible. She says this holds even if their Part D plan does not cover a GLP-1 for that condition.

How much does the Medicare GLP-1 Bridge Program cost per month?

She says the copay is $50 a month for eligible beneficiaries. The video names Wegovy, the QuickPen from Zepbound, and Foundayo as the included medications.

What can you do if Part D denies a GLP-1 and you do not qualify for Bridge?

She suggests asking your plan why you were denied and what appeal options you have. She also recommends making sure your health care provider understands the Bridge requirements and submits the prescription through the correct pathway.

Can you use Part D for a GLP-1 and switch to Bridge later?

She says it is not that simple. According to the video, CMS states that people who received a GLP-1 through Part D during 2026 are not eligible for Bridge in 2026.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Does Medicare cover GLP-1s? Ozempic, Wegovy and Zepbound, route by route

    Yes, by two different routes. Medicare drug plans (Part D, including Medicare Advantage plans with drug coverage) cover Ozempic and Mounjaro for type 2 diabetes. For weight loss, the Medicare GLP-1 Bridge covers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo for a $50 monthly copay from 1 July 2026 to 31 December 2027, if you meet CMS's BMI criteria. The catch: the Bridge runs outside Part D, so that $50 never counts toward your deductible or out-of-pocket cap.

  • Zepbound for sleep apnea: what the label approves, what SURMOUNT-OSA found, and who pays for it

    Zepbound is the only GLP-1 approved to treat moderate to severe obstructive sleep apnea, in adults with obesity, alongside diet and exercise. In the two 52-week SURMOUNT-OSA trials, breathing interruptions fell by about 25 to 29 events an hour on Zepbound against about 5 on placebo. The label's OSA maintenance dose is 10 mg or 15 mg a week. Because sleep apnea is a medical indication, Medicare's GLP-1 Bridge excludes it and points people to their Part D plan, which may cover it.

  • How to get a GLP-1 covered by insurance, in the order it actually works

    There are four gates and most people fight the wrong one first. Before any clinical criterion applies, your employer has to have bought the weight-loss drug category at all, and if they did not, no BMI number and no comorbidity will change the answer. Once past that, the published criteria across the major insurers are strikingly consistent: BMI of 30 or more, or 27 with a weight-related condition, plus a documented period of lifestyle change, plus roughly 5 percent weight loss to stay approved at renewal.

Next steps

Wegovy prices

Insurance

Find more like it

Cost and insurance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV